Medthority.com

Twice-yearly lenacapavir demonstrates sustained impact on health

WEBThese latest findings underscore the role of lenacapavir, the first long-acting injectable HIV treatment medication administered twice-yearly, as a person-centric …

Actived: 5 days ago

URL: https://www.medthority.com/news/2023/7/twice-yearly-lenacapavir-demonstrates-sustained-impact-on-health-related-quality-of-life-in-people-with-hiv.--gilead-sciences/

Health Canada approves Keytruda for adjuvant treatment of stage …

WEBMerck Inc. announced that Health Canada has granted approval for Keytruda (pembrolizumab), Merck's anti-PD-1 therapy, for the adjuvant treatment of …

Category:  Health Go Health

Opsynvi becomes the first and only Health Canada-approved once …

WEBThe Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada approved Opsynvi (macitentan 10mg and tadalafil 40mg) for the …

Category:  Health Go Health

Merck/Organon to acquire Alydia Health and with it Jade System …

WEBMerck and Alydia Health announced that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will …

Category:  Health Go Health

WHO launches health review after microplastics found in 90% of …

WEBThe World Health Organisation (WHO) has announced a review into the potential risks of plastic in drinking water after a new analysis of some of the world’s …

Category:  Health Go Health

BI 690517 ,an aldosterone synthase inhibitor on top of …

WEBMerck Inc. known as MSD outside of the United States and Canada, announced that the Phase III KEYNOTE-B21 trial evaluating Keytruda, Merck’s anti-PD …

Category:  Health Go Health

Vision for a better future: lessons from The Lancet Global Health

WEBVision impairment affects more than the individual, and its prevalence and impacts are of global concern. There are many strategies we can implement to help …

Category:  Health Go Health

Expert opinion – patient wellbeing in psoriasis

WEBIn this series of video clips, patient advocate Joel Nelson puts expert Dr Rachel Sommer in the question seat as they explore the burden of psoriasis on patients. …

Category:  Health Go Health

Health Canada approves Arexvy to prevent respiratory syncytial …

WEBHealth Canada has granted approval for GSK’s Arexvy vaccine to prevent respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRTD) in people …

Category:  Health Go Health

Health Canada approves Trodelvy for locally advanced or …

WEBGilead Sciences, Inc. announced that Health Canada has approved Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with …

Category:  Health Go Health

AstraZeneca launches Evinova a provider of digital health solutions.

WEBThe Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology …

Category:  Medical Go Health

Baxter highlights new data indicating Sharesource Digital Health

WEBBaxter International Inc. a global innovator in renal care,announced new data showing kidney patients may experience a survival rate nearly two-times higher and a …

Category:  Health Go Health

Ryaltris approved in Canada for the symptomatic treatment of …

WEBBausch Health Companies Inc. and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. announce that Ryaltris (olopatadine hydrochloride and …

Category:  Health Go Health

Amgen announces cardiovascular study to evaluate the …

WEBASCVD is defined as the buildup of cholesterol plaque in arteries and includes events such as heart attack and stroke. The African American Heart Study: is a …

Category:  Health Go Health

Novan to acquire dermatology company EPI Health

WEBNovan, Inc. announced its acquisition of EPI Health, LLC (“EPI Health”), a specialty pharmaceutical company focused on the U.S. dermatology market. “As we …

Category:  Health Go Health

FDA accepts NDA for IDP 126 gel triple therapy to treat acne

WEBBausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, announced that the FDA has accepted the NDA for investigational IDP …

Category:  Health Go Health

3M spins off Solventum as an independent healthcare company

WEB3M has announced Solventum will be the name of the planned, independent health care company following its spin-off. The new name and branding will go into …

Category:  Health Go Health

FDA accepts NDA for Zimura in geographic atrophy and sets

WEBPublished: 18th Feb 2023. IVERIC bio announced that the FDA has completed its filing review and accepted the company’s New Drug Application (NDA) for Zimura …

Category:  Health Go Health